| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.61B | 38.63B | 38.93B | 35.26B | 33.39B | 31.45B |
| Gross Profit | 12.32B | 16.48B | 16.10B | 13.56B | 13.07B | 12.07B |
| EBITDA | 4.58B | 9.08B | 9.54B | 8.38B | 9.53B | 5.03B |
| Net Income | 3.21B | 4.74B | 5.15B | 4.34B | 4.59B | 2.09B |
Balance Sheet | ||||||
| Total Assets | 71.19B | 69.31B | 71.52B | 57.31B | 51.05B | 43.77B |
| Cash, Cash Equivalents and Short-Term Investments | 10.29B | 3.82B | 5.52B | 11.80B | 7.09B | 5.39B |
| Total Debt | 1.17B | 2.30B | 5.29B | 1.21B | 131.00M | 200.00M |
| Total Liabilities | 31.12B | 33.72B | 37.35B | 31.55B | 26.56B | 24.02B |
| Stockholders Equity | 36.20B | 31.69B | 30.30B | 33.31B | 32.95B | 27.96B |
Cash Flow | ||||||
| Free Cash Flow | 2.75B | 4.12B | 1.63B | 5.87B | 4.32B | 4.08B |
| Operating Cash Flow | 3.98B | 6.93B | 4.15B | 7.75B | 6.13B | 5.32B |
| Investing Cash Flow | -2.33B | -2.13B | -9.69B | -1.06B | -2.75B | -1.07B |
| Financing Cash Flow | -3.56B | -6.49B | 927.00M | -811.00M | -1.37B | -1.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$83.38B | 13.36 | 14.96% | 4.69% | 1.51% | 5.50% | |
68 Neutral | HK$85.06B | -8.03 | 1.45% | 3.42% | -0.31% | 10.85% | |
63 Neutral | HK$99.54B | 26.31 | 5.74% | 5.59% | -9.54% | -27.75% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
54 Neutral | HK$478.17M | 6.04 | 10.82% | 4.07% | 2.77% | -110.76% |